 |
|
 |
 |

Home > Company Index > Drugs > Drug Delivery > DURECT Corporation
 |
DURECT Corporation |
 |
 |
 |
PROFILE |
 |
DURECT Corporation wants your medicine to go DURECTly where it's needed. The company is developing drug-delivery systems that provide long-term therapy for conditions such as chronic pain, cancer, diabetes, and arthritis. Its DUROS technology, licensed from ALZA, incorporates a reservoir and pump about the size of a matchstick implanted under the skin, with catheters attached to the affected organ. Tiny doses of potent medicine are dispensed regularly for up to a year, replacing the need for injections or daily oral doses. In 1999 DURECT bought InterEAR, which makes fluid-control catheters for the ear membrane. ALZA owns about 16% of DURECT, which has purchased Southern BioSystems.
COMPETITION |
 |
Alkermes, Inc. (ALKS)
Genetronics Biomedical Corporation (GEB)
Medtronic, Inc. (MDT)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 3.20
1-Yr. Sales Growth: 3,620.9%
Employees: 62
Revenue per employee: $51,612.90
KEY PEOPLE |
 |
James E. Brown
CEO
Thomas A. Schreck
CFO
CONTACT INFO |
 |
10240 Bubb Rd.
Cupertino, CA 95014
US
Phone: 408-777-1417
Fax: 408-777-3577
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |